Introduction
============

Aging is the major risk factor for cardiovascular diseases (CVD), as nearly 90% of incident CV events occur in adults over 55 years of age (Go *et al*., [@b4]). Stiffening of the large elastic arteries (aorta and carotid arteries) is a strong, independent predictor of cardiovascular events with aging (Sutton-Tyrrell *et al*., [@b10]; Mitchell *et al*., [@b6]), and superoxide-dependent oxidative stress and inflammation are key mechanisms by which large elastic arteries stiffen with age (Kim *et al*., [@b5]; Sindler *et al*., [@b9]; Fleenor *et al*., [@b3]).

Perivascular adipose tissue (PVAT) surrounds large elastic arteries and may exert an important influence on arterial stiffness. Visceral white adipose tissues from older mice demonstrate greater oxidative stress, which may lead to greater pro-inflammatory cytokine and chemokine secretion (Findeisen *et al*., [@b2]; Padilla *et al*., [@b7]). However, it is unknown whether the production of superoxide production and pro-inflammatory proteins from PVAT is increased with aging, and whether superoxide signaling in PVAT contributes to large artery stiffening with age.

Results
=======

Large elastic artery stiffness was greater in old compared with young control mice based on aortic pulse wave velocity (aPWV), the clinical gold standard measure (Sutton-Tyrrell *et al*., [@b10]; Mitchell *et al*., [@b6]) (Fig. [1A](#fig01){ref-type="fig"}), and *ex vivo* intrinsic mechanical stiffness (Fig. [1B](#fig01){ref-type="fig"}) (both, *P* \< 0.05). Treatment with TEMPOL, a superoxide dismutase mimetic (Simonsen *et al*., [@b8]), reduced aortic stiffness in old mice to levels not different from young control animals (Fig. [1A,B](#fig01){ref-type="fig"}). Aortic wall thickness, lumen diameter, and adventitial collagen I expression were greater in old compared with young control mice, and these differences were abolished with TEMPOL (Table [S1](#sd2){ref-type="supplementary-material"} and Fig. [S1](#sd2){ref-type="supplementary-material"}) (all, *P* \< 0.05). Arterial systolic, diastolic, and mean blood pressures were not different with aging or TEMPOL treatment (Table [S1](#sd2){ref-type="supplementary-material"}) as previously shown (Fleenor *et al*., [@b3]).

![Large elastic artery stiffness and perivascular adipose tissue (PVAT) superoxide production with aging and in TEMPOL-treated old mice. (A) Aortic pulse wave velocity (aPWV), (B) *ex vivo* arterial stiffness, and (C) PVAT superoxide production in young, old, and old TEMPOL (1 m[m]{.smallcaps})-treated mice (*N* = 4--6/group); Values are means ± S.E. \**P* \< 0.05 vs. Young and Old TEMPOL.](acel0013-0576-f1){#fig01}

Superoxide production was increased in whole tissue samples of PVAT surrounding the thoracic aorta (Fig. [1C](#fig01){ref-type="fig"}), and in adipocytes isolated from PVAT of old control compared with young control mice (Fig. [S2](#sd2){ref-type="supplementary-material"}) (both, *P* \< 0.05). TEMPOL normalized aortic PVAT superoxide production in whole tissue samples from old mice to young control levels (Fig. [1C](#fig01){ref-type="fig"}) (*P* \< 0.05).

Because excessive superoxide production induces inflammation, we assessed the secretion of pro-inflammatory cytokines/chemokines in PVAT-conditioned media. The pro-inflammatory cytokines/chemokines GM-CSF, IL-6, CXCL1, CCL2/MCP-1, CXCL2 were greater in PVAT-conditioned media from old compared with young control mice (Fig. [S3](#sd2){ref-type="supplementary-material"}) (all, *P* \< 0.05). C5/C5a and TIMP-1 were also detected in conditioned media from old mice, but not from young controls (Fig. [S3](#sd2){ref-type="supplementary-material"}).

Thoracic aorta PVAT was removed from young control, old control, and old TEMPOL-treated donors and transplanted directly onto the abdominal aorta of young recipient mice for 8 weeks (Fig [2A](#fig02){ref-type="fig"}). Young recipient mice transplanted with PVAT from old animals had greater aortic stiffness as indicated by increased aPWV and *ex vivo* intrinsic mechanical stiffness compared with those transplanted with PVAT from young donors (Fig. [2B,C](#fig02){ref-type="fig"}) (both, *P* \< 0.05). TEMPOL treatment in old donors abolished the increases in aPWV and *ex vivo* intrinsic mechanical stiffness observed with transplantation into young recipient mice (Fig [2B,C](#fig02){ref-type="fig"}) (both, *P* \< 0.05).

![Effects of perivascular adipose tissue (PVAT) on large elastic artery stiffness. (A) Thoracic PVAT was removed from donor mice and transplanted into young recipient for 8 weeks. (B) Aortic pulse wave velocity (aPWV) and (C) *ex vivo* arterial stiffness in young recipient mice receiving PVAT from young, old, and old TEMPOL-treated donors after 8 weeks. (D) Arterial stiffness in aortic segments cultured for 72 h with (+) or without (−) perivascular adipose tissue from additional young and old control mice in the presence (+) or absence (−) of TEMPOL (*N* = 4--6/group); Values are means ± S.E. \**P* \< 0.05 vs. all; \# *P* \< 0.05 vs. Young PVAT and Old TEMPOL PVAT; \$*P* \< 0.05 vs. Young; Old PVAT (−), TEMPOL (−) and Old PVAT (+), TEMPOL (+).](acel0013-0576-f2){#fig02}

Wall thickness and adventitial collagen I expression were greater in young recipient mice transplanted with PVAT from old control compared with young control PVAT donors (both, *P* \< 0.05), an effect that was not observed with PVAT donated from TEMPOL-treated old animals (Table [S2](#sd2){ref-type="supplementary-material"} and Fig. [S4](#sd2){ref-type="supplementary-material"}). Lumen diameter and arterial systolic, diastolic, and mean blood pressures were not significantly different between groups (Table [S2](#sd2){ref-type="supplementary-material"}).

To further determine the effects of PVAT on arterial stiffness, aortic segments from additional young and old control mice were cultured in the presence (+) or absence (-) of PVAT for 72 h. Intrinsic mechanical stiffness was greater in aortic segments from old (+) PVAT compared with all aortic segments from young control mice (Fig. [2D](#fig02){ref-type="fig"}) (all, *P* \< 0.05). Compared with aortic segments from old (−) PVAT, samples from old (+) PVAT had greater intrinsic stiffness (Fig. [2D](#fig02){ref-type="fig"}) (*P* \< 0.05). TEMPOL reversed the intrinsic mechanical properties in arterial segments (+) PVAT to levels similar to old (−) PVAT (Fig. [2D](#fig02){ref-type="fig"}) (*P* \< 0.05).

Discussion
==========

The present study provides the first evidence directly linking PVAT with large elastic artery stiffness. The effects of PVAT from old mice in the promotion of arterial stiffening were demonstrated *in vivo* using a fat transplant model and in an *in vitro* tissue culture model. Importantly, superoxide production in PVAT from older animals was shown to be greater, and this was normalized with TEMPOL treatment, which, in turn, reversed PVAT-mediated arterial stiffening. The age-related increase in PVAT superoxide oxide production was associated with increased cytokine and chemokine secretion, indicating superoxide signaling may promote inflammation in PVAT. We also confirm the superoxide-lowering effect of TEMPOL to improve arterial function in old mice, suggesting excessive superoxide signaling is an important process in arterial stiffening (Fleenor *et al*., [@b3]). Arterial blood pressure can influence arterial stiffening; however, blood pressure was not different with aging or TEMPOL. Finally, our results suggest that superoxide signaling within PVAT may play an important role in the increase in aortic wall thickness and adventitial collagen I expression with aging.

Perivascular adipose tissue surrounding the thoracic aorta has been shown to resemble the phenotype of brown adipose tissue (Cannon & Nedergaard, [@b1]; Padilla *et al*., [@b7]). Assessing the phenotype, including inflammatory pathways, of thoracic aorta PVAT and whether the phenotype changes with transplantation is of interest and should be examined in future investigations.

In conclusion, our results provide the first evidence for aortic PVAT as a novel mechanism and potential therapeutic target in large elastic artery stiffening and increased CVD risk with aging.
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**Table S1** Arterial morphology and blood pressure in young, old and old TEMPOL-treated mice.

**Table S2** Arterial morphology and blood pressure in young recipient mice after transplanted with PVAT from young, old or old TEMPOLtreated donors for 8 weeks.

**Fig. S1** Adventitial collagen I expression in young, old and old TEMPOL-treated mice.

**Fig. S2** Superoxide production in adipocytes isolated from PVAT of young and old mice.

**Fig. S3** Cytokine secretion profile of cultured PVAT from young and old mice.

**Fig. S4** Adventitial collagen I expression in young recipient mice transplanted with PVAT from young, old or old TEMPOL donors.
